Drug intelligence / Profile preview

Resfenol

Development stage
Phase 3
Lead developer
Hertz
Modality
Small Molecules
Administration
Oral
01

Overview

**Resfenol** is a Brazilian fixed-dose oral cold and flu medicine manufactured by Hertz. The base Resfenol products combine paracetamol, chlorpheniramine maleate, and phenylephrine hydrochloride to provide analgesic and antipyretic activity, H1-antihistamine relief of rhinorrhea and allergic symptoms, and alpha-1 adrenergic nasal decongestion. It is marketed for symptomatic treatment of influenza and the common cold, including fever, headache, myalgia, nasal obstruction, and rhinorrhea. Official product information describes capsule, oral-solution, and powder-for-oral-solution presentations. ([hertzfarma.com.br](https://www.hertzfarma.com.br/produto/resfenol/))

Brand names
Resfenol
Other names
cloridrato de fenilefrina + paracetamol + maleato de clorfeniraminaparacetamol + chlorpheniramine maleate + phenylephrine hydrochlorideparacetamol + maleato de clorfeniramina + cloridrato de fenilefrina
02

Targets

ADRA1A (α1A)COXHRH1 (Histamine H1 Receptor)

Beyond the preview

Go deeper on Resfenol.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Resfenol.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call